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Twin arginine translocationa b s t r a c t
The Tat machinery translocates fully-folded and oligomeric substrates. The passage of large, bulky
cargos across an ion-tight membrane suggests the need to match pore and cargo size, and therefore
that Tat transport efﬁciency may depend on both cargo size and shape. A series of cargos of different
sizes and shapes were generated using the natural Tat substrate pre-SufI as a base. Four (of 17) car-
gos transported with signiﬁcant (>20% of wild-type) efﬁciencies. These results indicate that cargo
size and shape signiﬁcantly inﬂuence Tat transportability.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The twin arginine translocation (Tat) machinery transports
fully-folded and assembled cargos from the Escherichia coli cyto-
plasm to the periplasm [1]. In the predominant model of Tat-
dependent transport, cargos ﬁrst interact with a receptor complex
comprised of TatB and TatC, and then are conveyed across the bi-
layer though a channel composed primarily of TatA [2,3]. The sig-
nal peptide is removed after transport by a periplasmic peptidase
resulting in the mature form of the protein [4].
The Tat machinery can potentially be used to produce protein
products [5,6]. For increased ease and rapidity of puriﬁcation, the
bacterial Sec system has long been used to transport proteins of
interest into the periplasm or outside of the cell [7]. The Sec sys-
tem, however, cannot transport proteins that are oligomeric or
fast-folding, or that require cytoplasmic reagents for cofactor
assembly and insertion. The Tat translocase offers an attractive
alternative pathway that, in principle, could accommodate these
problematic substrates. Additionally, the Tat translocase possesses
a poorly understood quality control mechanism that appears to be
able to prevent incorrectly folded cargos from transporting, which
would presumably allow for isolation of only correctly folded pro-
teins [8,9]. In order to make efﬁcient use of the Tat system in this
way, it is important to understand the limitations of the machin-
ery, especially its capability to translocate unnatural substrates.The Tat system’s ability to transport hetero-oligomeric proteins
with only a single signal peptide has been termed the ‘‘hitch-hiker’’
mechanism. For example, the small (HybO) and large (HybC) sub-
units of E. coli hydrogenase 2 are transported together, with HybO
responsible for the co-transport of HybC [10]. The catalytic dimer
of dimethyl sulfoxide reductase (DmsAB) also has only a single sig-
nal peptide, which is found on DmsA [11]. Despite the presence of
these naturally occurring hitch-hiker complexes, efforts to trans-
port ‘‘unnatural’’ non-covalent hetero-dimers have been unsuc-
cessful. Two studies that address this directly utilized
biotinylated natural cargo bound to avidin tetramers. In both in-
stances, the proteins (OE17 and SufI) failed to transport under
in vitro conditions, despite binding to the Tat translocon [12,13].
These bound, non-transportable cargos were not, however, dead-
end intermediates (i.e., they were not ‘‘stuck’’ in the translocon)
because they could be exchanged for different cargos that were
subsequently transported.
The size limitations of the Tat machinery have been probed
with natural Tat substrates or signal peptides fused to a separate
protein domain. When the natural chloroplast Tat substrate OE17
was fused to a Protein A moiety separated by varying lengths of
unstructured linkers [14], the fused cargos failed to fully transport.
The fusions with the longest linkers formed membrane spanning
intermediates that were not associated with the translocon. Green
ﬂuorescent protein (GFP) was translocated into inverted mem-
brane vesicles (IMVs) containing the E. coli Tat system when it
was fused to the signal peptide of pre-TorA [15], but it did not
transport or even bind to the translocon when it was fused to
the signal peptide of pre-SufI [15].
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on cargo size, shape, and even the mature domain itself. Conse-
quently, we probed Tat translocation efﬁciency with various mod-
iﬁed forms of the natural cargo pre-SufI of different sizes and
shapes, ensuring that the core signal peptide and mature domain
recognition motifs remained present. We used a GFP fusion and
non-covalent pre-SufI-avidin hetero-dimers formed from biotinyl-
ated versions of single cysteine mutants [16]. The naturally occur-
ring, high afﬁnity, dimeric avidin homolog, rhizavidin, was
compared with tetrameric avidin [17]. Our results indicate that
transport efﬁciency is dependent on both molecular weight and
shape.
2. Methods
2.1. Bacterial strains, plasmids, and growth conditions
IMVs were prepared from E. coli strain MC4100DTatABCDE
overexpressing TatA, TatB and TatC from plasmid pTatABC by
induction with 0.6% arabinose, as previously described [15,16].
Plasmid pPre-SufI-GFP was generated by PCR ampliﬁcation of
the GFP gene from plasmid spTorA-GFP [15] using primers
50-AAAACTCGAGGATCGGCGCAAGCGGCGCGTAAAGGA-30 (forward)
and 50-AAAAGCTAGCTTTGTATAGTTCATCCATGACCATGCCATGTC-30
(reverse), which introduced two ﬂanking restriction sites (NheI
and XhoI). The GFP gene was inserted into pSufI-MCC [13] at
NheI/XhoI between the coding sequences for pre-SufI and the 6xHis
tag. A frame shift error was corrected by XhoI digestion and Klenow
fragment ﬁll-in (Fig. S1). Because the pre-SufI-GFP fusion protein is
too large to be readily distinguished on an SDS–PAGE gel from the
mature SufI-GFP protein, the coding sequence for pre-SufI-GFP was
inserted into pTYB11 (New England Biolabs) with SapI/NheI gener-
ating pIntein-pre-SufI-GFP (Fig. S2), which allowed puriﬁcation of
only the full length precursor, as described previously [16].
The pre-SufI single cysteine mutants necessary for the pre-
SufIbiotin experiments were produced as described previously
[16]. The rhizavidin expression plasmid was a gift from Barbara
Niederhauser [17].
2.2. Protein puriﬁcation, labeling and detection
Pre-SufI cysteine mutants and pre-SufI-GFP were expressed
and puriﬁed, as described [16]. Cysteines were biotinylated with
N-(3-maleimidylpropionyl)biocytin (Invitrogen) [13]. RhizavidinFig. 1. Location of single cysteine mutations on the surface of pre-SufI. Sites where
residues were mutated to cysteine are indicated in red or yellow (PDB accession
number: 2UXT). Biotinylated mutants that had transport efﬁciencies >20% in the
presence of rhizavidin (Fig. 3C) are identiﬁed in red. All other cysteine locations are
yellow.was puriﬁed as described [17], and labeled with Alexa532-succin-
imide with a 20-fold molar excess of dye for 1 h at room tempera-
ture in 100 mM sodium bicarbonate (pH 8.25). The reaction was
quenched with 100 mM Tris–HCl (pH 8.0), ﬁnal concentration.
Excess dye was removed by spin ﬁltration with addition of fresh
bicarbonate buffer after each spin (8 consecutive 5 min spins at
10000 rcf) using Pall Nanosep Omega spin-ﬁlters (3000 MW cut-
off). Untransported rhizavidin could not be removed by proteinase
K digestion, due to the protein’s resistance to proteolytic digestion
[17], so it was removed by centrifugation with translocation buffer
containing 2 M urea and 1 M KCl to separate the pre-SufI/rhizavi-
din complex from the IMVs [13]. The term ‘‘avidin’’ refers to the
glycosylation free variant NeutrAvidin (Invitrogen).
Most proteins were detected by Western blotting using avidin-
HRP and chemilumescence [13]. RhizavidinAlexa532 was detected by
in-gel ﬂuorescence imaging (model FX PhosphorImager, Bio-Rad
Laboratories). In Fig. 2, pre-SufI and pre-SufI-GFP were detected
by anti-SufI immunoblotting.
2.3. Transport reactions
Protein translocation assays were performed essentially as de-
scribed [15]. Unless otherwise noted, initial precursor concentra-
tions were 90 nM. Errors are reported as S.E.M. IMV
concentration was standardized using the absorbance at 280 nm
in 2% SDS [15]. For all translocation reaction reported here, A280 = 5.
3. Results
3.1. Pre-SufI cargos
The natural Tat substrate, pre-SufI, was selected as a template
for a series of cargos based on its relatively high transport efﬁ-
ciency [13,15]. For initial experiments, GFP was fused to the pre-
SufI C-terminus, generating a cargo with a molecular weight of
86 kDa. C-terminal fusions with authentic Tat cargos have been de-
scribed earlier [12,14,18]. Our goal, however, was to examine Tat
transport efﬁciency for a range of cargos that differed not only in
size, but in shape. To this end, a series of 8 single cysteine mutants
were utilized (Fig. 1). When the biotinylated pre-SufI mutants were
mixed with saturating levels of avidin, the pre-SufIbiotin/avidin
complexes all had a MW of 113 kDa, but with 8 distinct
morphologies.Fig. 2. Pre-SufI-GFP transports with limited efﬁciency. In vitro transport assays
with 50 nM pre-SufI (lanes 1–5) and pre-SufI-GFP (lanes 6–10). Precursor (p) and
matured (m) protein bands are identiﬁed. Pre-SufI-GFP transported 17% as
efﬁciently as pre-SufI (compare lane 10 to lane 5), based on the concentration
standards (lanes 1–3 and 6–8). Lanes 4 and 9 are minus PMF controls. Proteinase K
was added to lanes 4, 5, 9, and 10. Bands were visualized by anti-SufI
immunoblotting.
Fig. 3. Pre-SufIbiotin transports in the presence of rhizavidin with limited and shape-dependent efﬁciency. (A&B) Pre-SufIbiotin transport efﬁciency in the presence of (A) avidin
tetramers and (B) rhizavidin dimers. When present, biotin (36 lM) was in large excess over (rhiz)avidin (3.6 lM), and (rhiz)avidin was in large excess over the precursor
protein (90 nM, 3.1 pmol). Thus, the binding interactions were saturated. The graphs represent an average of three independent experiments, normalized to transport in the
absence of (rhiz)avidin and biotin (control). (C) Transport efﬁciency of the pre-SufIbiotin mutants in the presence of avidin (red) and rhizavidin (blue), calculated by comparing
+ and  biotin conditions. (D) An example of the transport reactions in (A) and (B) for a pre-SufIbiotin mutant that transported in the presence of rhizavidin, but not avidin
(M338C), and a mutant that did not transport under either condition (G410C). All reactions were energized with NADH. Proteins were detected by Western blotting using
avidin-HRP.
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etli, is a naturally occurring, dimeric homolog of avidin. It does
not have the 1–2 and 1–3 interfaces that tetrameric avidin has,
yet it still maintains a high afﬁnity for biotin [17,19]. Complexes
of the biotinylated pre-SufI mutants and rhizavidin have a MW
of 83 kDa.
3.2. Transport efﬁciencies of modiﬁed pre-SufI proteins
Transport efﬁciencies for all pre-SufI constructs were measured
using the in vitro transport assay described previously, which re-
lies on the appearance of a protease protected mature protein
[15]. In short, cargo protein was mixed with IMVs containing
over-expressed TatABC. Membranes were energized by addition
of NADH, which promotes translocation of the cargo into the lu-
men of the vesicles. After 30 min, reactions were treated with Pro-teinase K, which digests any untranslocated cargo. The resultant
mixtures were resolved via SDS–PAGE and visualized by Western
blotting.
Pre-SufI-GFP was inefﬁciently transported (17% of wild-type
SufI; Fig. 2). Since GFP is not transported when fused to the SufI
signal peptide, but it is transported when fused to the TorA signal
peptide [15], these data indicate that the mature domain of pre-
SufI plays an important role in the ability of the translocon to
transport the GFP domain.
Transport efﬁciencies were also determined for the biotinylated
pre-SufI single cysteine mutants in the presence of avidin or rhiz-
avidin (Fig. 3). All pre-SufIbiotin proteins transported inefﬁciently, or
not at all, when bound to the avidin tetramer (Fig. 3A), consistent
with our previous report on a C-terminally biotinylated pre-SufI
protein [13]. Rhizavidin was also highly effective in blocking trans-
port, though, in some cases, signiﬁcantly less effective than avidin
Fig. 4. Rhizavidin is translocated into the lumen of IMVs. (A) Transport of pre-
SufI(M338C)biotin in the presence of rhizavidinAlexa532. Lanes 4 and 5 show the
amount of IMV-associated SufI(M338C)biotin (top) or rhizavidinAlexa532 (bottom).
Instead of protease treatment, IMVs were washed with KCl/urea (see Methods).
Biotin (36 lM) was absent/present as indicated. Pre-SufI(M338C)biotin was detected
by Western blotting using avidin-HRP (top), and rhizavidinAlexa532 was detected by
in-gel ﬂuorescence imaging (bottom). Lanes 1–3 are concentration standards. (B)
Bar graph of averaged data of the type shown in (A), showing the total amount of
transported rhizavidin (red) and pre-SufI (blue) (N = 3). The transported rhizavidin
in the presence of excess biotin was below the quantiﬁable range and taken to be
zero.
Fig. 5. Transport kinetics of pre-SufI(M338C)biotin in the presence and absence of
bound rhizavidin. (A) Time courses of pre-SufI(M338C)biotin translocation in the
presence of 3.6 lM rhizavidin and either the presence (bottom gel) or absence (top
gel) of 36 lM biotin. Reactions were performed at 37 C by removing aliquots at the
time points indicated and adding them to chilled tubes containing nigericin and
valinomycin (5 lM ﬁnal of each) to quench the reactions. Bands were visualized by
Western blotting using avidin-HRP. The exposure times are different, so intensities
are not directly comparable. (B) Quantiﬁcation of kinetic data like that in (A). The
amount of transported protein for the 30 min timepoint was determined by
comparison to concentration standards, and was then used to determine the
amount of transported protein at the remaining timepoints. Only the mature length
protein (m) was quantiﬁed (N = 3).
N. Whitaker et al. / FEBS Letters 587 (2013) 912–916 915(Fig. 3B). To conﬁrm that the effects of (rhiz)avidin were due to
speciﬁc interactions with biotin and to correct for any possible ef-
fects of (rhiz)avidin on transport, control experiments were per-
formed in which free biotin was added before (rhiz)avidin
(Fig. 3A and B). Transport efﬁciencies were then calculated relative
to this free biotin control for both avidin and rhizavidin (Fig. 3C).
Using this deﬁnition, the transport efﬁciencies for all pre-SufIbiotin/
avidin complexes were 615%. However, transport efﬁciencies of
28%, 39%, and 28% were observed in the presence of rhizavidin
for the T96C, M338C, and T479C mutants, respectively (Fig. 3C).
Based on the high afﬁnity of the biotin-avidin interaction (KD
1015 M, which predicts soff on the order of days) [20], the pre-
SufIbiotin/avidin complexes were expected to remain intact during
in vitro Tat dependent transport, which takes place within a few
minutes [16]. To test whether the pre-SufIbiotin/avidin complex
was transported intact, we assayed for the presence of ﬂuorescent
rhizavidin (rhizavidinAlexa532) in the IMV lumen for the most efﬁ-
ciently transported pre-SufI mutant. More rhizavidin was recov-
ered with IMVs in the absence than in the presence of free biotin
(Fig. 4). Thus, more rhizavidin was recovered with the IMVs under
conditions where it is able to bind to the precursor protein. It is un-
likely that the N-(3-maleimidylpropionyl)biocytin linker (2 nm in
length) was able to span the lipid bilayer, allowing the pre-SufI
protein to be transported while leaving the rhizavidin outside.
Thus, we conclude that rhizavidin was transported into the IMV lu-
men while bound to pre-SufI(M338C)biotin. We had some difﬁculty
with complete removal of untransported cargo protein without
protease digestion. This may account, at least in part, for the higher
amount of transported cargo than the transported rhizavidin. How-ever, it is also possible that some unbound pre-SufI was trans-
ported despite a 10-fold molar excess of rhizavidin.
Transport efﬁciencies were calculated by determining the
amount of transported protein at a single time point (30 min). To
test whether lower pre-SufIbiotin transport efﬁciencies in the pres-
ence of rhizavidin can be explained by slower transport rates, the
time dependence of pre-SufI(M338C)biotin transport in the presence
and absence of bound rhizavidin were compared (Fig. 5A). In both
the presence and absence of bound rhizavidin, the amount of
transported SufI(M338C)biotin saturated at 20 min (Fig. 5B), indi-
cating that the single time point data (30 min) accurately reports
overall transport efﬁciency.
4. Discussion
Previous studies of Tat cargo translocation efﬁciencies have
probed the role of the overall molecular weight and the total length
of a linker between two folded domains [14,21]. The current study
has methodically examined, for the ﬁrst time, the Tat machinery’s
ability to transport cargos of different sizes and shapes, while
attempting to minimize changes to the overall charge of the pro-
tein, the surface charge, the signal peptide, and the ability of the
translocon to bind to the signal peptide. Our major ﬁndings are
that the size of linked protein and the location of the linkage be-
tween two folded domains spaced by a short (2 nm) linker signif-
icantly affects cargo transport efﬁciency. These data therefore
indicate that the overall size and shape of a cargo vis-à-vis the sig-
nal peptide are important for the Tat machinery’s ability to accom-
modate a cargo for transport.
In all cases, the presence of a bound avidin tetramer substan-
tially inhibited pre-SufIbiotin transport (615% of wildtype;
Fig. 3A). In most cases, the transport inhibition by rhizavidin was
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exception, but the quantiﬁcation of very low transport efﬁciencies,
which are determined from ﬂuorescent gels, are somewhat error-
prone. In addition to the size differences of avidin and rhizavidin,
their pI’s (6.3 and 4.0, respectively) and/or different surface charge
distributions may also contribute to interactions with the Tat
transport system. Proteins larger than the pre-SufIbiotin/avidin
complexes appear to be transported under natural conditions
[22]. In our in vitro experiments, the duration, and possibly the
magnitude, of the membrane potential are not as high or as long
as they are expected to be under in vivo conditions. So, higher
energetic input could be required for the transport of larger pro-
teins, as concluded earlier [21].
The various pre-SufIbiotin/rhizavidin complexes had highly
variable transport efﬁciencies (from 0 to 40%; Fig. 3C). Residue
modiﬁcation does not explain these results. Alexa532 labeling at
the pre-SufI single cysteine sites had little effect on transport
(>80% of wildtype), although a slightly greater effect was observed
near the signal peptide (G29C and G45C, 66–75% of wildtype) [16].
Attachment of biotin at these cysteines had little effect on trans-
port (P85% of wildtype, not shown). Thus, the poor transport of
the pre-SufIbiotin/rhizavidin complexes is most likely due to the
rhizavidin domain bound to the biotin moiety, and the range of
transport efﬁciencies is most likely due to the different three-
dimensional shapes vis-à-vis the signal peptide when the com-
plexes are presented to the Tat system for transport. The three
mutations that yielded the highest transport efﬁciencies in the
presence of rhizavidin, T96C, M338C, and 479C, are widely dis-
persed over the preSufI surface. T96 and M338 are on opposite
sides, and residue 479 is on the side opposite of the signal peptide
(Fig. 1). Since the S204C and G45C mutations are similarly distant
from the signal peptide as T96C and M338C, i.e., near the ‘equator’
in Fig. 1, we suggest that the cargo is likely not allowed to freely
rotate when bound to the Tat translocon. No transport of the
L470C mutant was detected, indicating that the ﬂexible linker be-
tween L470 and 479C is crucial for the transport machinery to
accommodate a rhizavidin domain attached to the 479 position.
The transport kinetics of pre-SufI(M338C)biotin/rhizavidin were
examined (Fig. 5) to determine whether the lower observed trans-
port efﬁciencies determined from single timepoint data (Fig. 3)
could be explained by a slower transport rate. The amount of trans-
ported pre-SufI(M338C)biotin/rhizavidin complex clearly plateaued
at a lower overall transport efﬁciency as compared to the rhizavi-
din-free precursor protein, indicating that longer reaction times
would not result in more translocated cargo. Further work will
be required to identify the exact effect of cargo shape on transport
efﬁciency.
The Tat machinery’s ability to translocate folded and oligomeric
proteins will likely continue to attract attention for the production
and puriﬁcation of proteins that cannot be secreted by the more
commonly used Sec system. This study implies that not every
tightly folded protein can be secreted by the Tat machinery when
coupled to a readily recognizable transportable carrier cargo. Thus,
we still have much to learn about the recognition, size, and shape
requirements of Tat cargos.
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